Registered number: 03847035
FOR THE YEAR ENDED 31 DECEMBER 2025
FACI ECHEM LTD
COMPANY INFORMATION
FACI ECHEM LTD
CONTENTS
FACI ECHEM LTD
STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2025
The directors present their strategic report for the year ended 31 December 2025.
FACI eChem Ltd specialises in the production and distribution of high-performance chemical additives used in a wide range of industrial applications, including plastics, rubber, coatings, construction materials, pharmaceuticals and personal care products. The Company forms part of the FACI Group, an international oleochemical group operating through manufacturing and commercial subsidiaries across Europe, Asia and North America
The Company delivered a strong financial performance during 2025 despite a market environment characterised by continued uncertainty in the European manufacturing sector and ongoing volatility in raw material markets.
Turnover increased slightly from £9.6 million to £9.8 million, while profitability improved significantly. Profit before taxation increased from £559k to £1.1 million and profit after taxation increased from £406k to £816k. Net assets increased from £8.0 million to £8.8 million.
The improvement in profitability was supported by continued cost discipline, efficient management of working capital and a favourable contribution from financial income and foreign exchange movements.
As an export-oriented business, the Company generates a significant proportion of its sales in Euro while a substantial part of its operating cost base is denominated in Pound Sterling. During 2025, exchange rate movements had a positive impact on the Company's results and contributed to the improvement in profitability.
Credit Risk
The Company maintains a diversified and well-established customer portfolio. Credit exposure is continuously monitored and customer credit limits are regularly reviewed. No significant bad debts were incurred during the year.
Liquidity Risk
The Company operates within the Group's treasury structure and continues to benefit from the financial support and cash management arrangements of the wider FACI Group. The Directors are satisfied that sufficient financial resources are available to support ongoing operations.
Foreign Exchange Risk
The Company is exposed to currency fluctuations arising from sales and purchases denominated in different currencies, principally EUR and GBP. Exchange rate movements are monitored continuously and managed through the Group treasury function.
Market Risk
The European manufacturing sector continues to face challenges linked to geopolitical uncertainty, regulatory developments and weak industrial demand. The Company mitigates these risks through product diversification, long-standing customer relationships and a focus on speciality products with higher added value.
Page 1
FACI ECHEM LTD
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
Research and development activities are coordinated at Group level. The Company continues to benefit from technical knowledge, product development and regulatory support provided by other companies within the FACI Group.
The company's key financial and other performance indicators during the year were as follows:
The Company recorded a modest increase in both turnover and sales volumes during the year. Whilst market conditions in the United Kingdom remained challenging, particularly in the industrial and manufacturing sectors, the Company benefited from a favourable product mix and from export sales that partially offset the continuing contraction of domestic demand.
The Company recorded a modest increase in both turnover and sales volumes during the year. Whilst market conditions in the United Kingdom remained challenging, particularly in the industrial and manufacturing sectors, the Company benefited from a favourable product mix and from export sales that partially offset the continuing contraction of domestic demand.
The markets served by the Company continue to be influenced by a combination of economic uncertainty, geopolitical tensions and increasing competitive pressure from non-European producers. These factors have affected customers’ investment decisions and, more generally, the level of industrial activity across several sectors in which the Company operates.
Despite these challenges, the Company maintained satisfactory operating performance and profitability. The business continued to benefit from its established customer base, technical expertise and close integration within the wider FACI Group.
A particularly positive contribution to the result for the year arose from foreign exchange movements. The Company’s sales are predominantly denominated in Euro whilst a significant proportion of purchases are made in Pound Sterling. During 2025, exchange rate movements generated a favourable impact on profitability, contributing to the improvement in profit before tax compared with the previous year.
Raw material markets remained characterised by volatility throughout the year. Prices of vegetable oils, fatty acids and their derivatives continued to be influenced by geopolitical developments, transportation costs, regulatory requirements and uncertainty surrounding international trade policies. Whilst fluctuations were generally less extreme than in previous years, they remained frequent and difficult to predict.
The Company continues to operate within the Group cash pooling structure managed by Faci Corporate S.p.A. This centralised treasury system optimises liquidity management across the Group and provides financial flexibility to support working capital requirements and future development opportunities. The Directors remain satisfied with the overall financial strength of the Group and the Company's position within it.
Page 2
FACI ECHEM LTD
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
The Directors expect market conditions during 2026 to remain challenging and characterised by a high degree of uncertainty. Ongoing geopolitical tensions, changes in international trade policies and the continuing pressure on European industrial production are expected to influence customer demand and investment decisions.
The European chemical industry continues to face structural challenges, including high energy costs, increasing regulatory requirements and competition from producers operating in regions with lower production costs and less burdensome regulatory frameworks. These factors may continue to affect the markets served by the Company.
Despite these challenges, the Directors believe that the Company is well positioned to continue operating successfully. The business benefits from a diversified customer portfolio, strong technical know-how and the support of the wider FACI Group. The Company has also demonstrated resilience in adapting to changing market conditions and maintaining profitability despite a difficult economic environment.
The Directors expect export activity to continue to play an important role in supporting sales performance and partially mitigating the effects of the gradual decline in domestic industrial demand.
Although visibility remains limited and forecasting beyond the short term remains difficult, current trading and customer discussions provide grounds for cautious confidence. The Directors therefore believe that the Company is well placed to maintain satisfactory operating performance during 2026.
Going concern
The financial statements have been prepared on a going concern basis for a period of at least twelve months from the date of approval of these financial statements.
The Directors have assessed the Company's ability to continue as a going concern taking into consideration its financial performance, forecast cash flows, available financing arrangements and the continued support of the wider FACI Group.
As part of the Group's centralised treasury management arrangements, surplus cash balances are regularly transferred to the parent company, Faci Corporate S.p.A.The Directors are satisfied, by virtue of the involvement of F. Rossi in the board of the ultimate parent company, Euchemia S.p.A., which provides direct knowledge of the Group's financial position and strategic priorities, that the Group has both the intention and the ability to continue making available such funds as are needed by the Company for at least twelve months from the date of approval of these financial statements and for the foreseeable future.
The Directors have reviewed the Company's forecasts and considered the principal risks and uncertainties affecting the business. Based on this assessment, together with the financial resources available within the Group, they have a reasonable expectation that the Company will continue to operate and meet its obligations as they fall due.
Accordingly, the Directors consider it appropriate to prepare the financial statements on the going concern basis.
This report was approved by the board on 16 July 2026 and signed on its behalf.
Page 3
FACI ECHEM LTD
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2025
The directors present their report and the financial statements for the year ended 31 December 2025.
The profit for the year, after taxation, amounted to £816,004 (2024 - £406,143).
No dividends were paid during the year.
The directors do not recommend the payment of a dividend.
The directors who served during the year were:
The directors are responsible for preparing the Strategic Report, the Directors' Report and the financial statements in accordance with applicable law and regulations.
In preparing these financial statements, the directors are required to:
∙select suitable accounting policies for the Company's financial statements and then apply them consistently;
∙make judgments and accounting estimates that are reasonable and prudent;
∙state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements;
∙prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and to enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Page 4
FACI ECHEM LTD
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
The company made no political donations or incurred any political expenditure during the year.
An indication of likely future developments in the business and particulars of significant events which have occurred since the end of the financial year have been included in the strategic report.
The Directors are not aware of any significant events occurring after the balance sheet date requiring disclosure in these financial statements.
The auditors, MHA Audit Services LLP , will be proposed for reappointment in accordance with Chapter 3 of Part 16 of the Companies Act 2006.
This report was approved by the board on 16 July 2026 and signed on its behalf.
Page 5
FACI ECHEM LTD
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF FACI ECHEM LTD
Opinion
We have audited the financial statements of Faci Echem Ltd (the ‘company’) for the year ended 31 December 2025 which comprise the statement of comprehensive income, balance sheet, statement of changes in equity and notes to the financial statements, including material accounting policies. The financial reporting framework that has been applied in the preparation of the company’s financial statements is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
In our opinion the financial statements:
∙give a true and fair view of the state of the Company’s affairs as at 31 December 2025 and of the Company’s profit for the year then ended;
∙have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
∙have been prepared in accordance with the requirements of the Companies Act 2006.
Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our ethical responsibilities in accordance with those requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the Directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
Other information The other information comprises the information included in the annual report other than the financial statements and our auditor’s report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
Page 6
FACI ECHEM LTD
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF FACI ECHEM LTD
In our opinion, based on the work undertaken in the course of the audit:
∙the information given in the strategic report and the directors’ report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
∙the strategic report and the directors’ report have been prepared in accordance with applicable legal requirements.
In the light of the knowledge and understanding of the Company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors’ report.
Matters on which we are required to report by exception
We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
∙adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
∙the financial statements are not in agreement with the accounting records and returns; or
∙certain disclosures of directors’ remuneration specified by law are not made; or
∙we have not received all the information and explanations we require for our audit
Responsibilities of directors
As explained more fully in the directors’ responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, the directors are responsible for assessing the Company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the Company or to cease operations, or have no realistic alternative but to do so.
Auditor responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists.
Misstatements can arise from fraud or error and are considered material if, individually or in aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The specific procedures for this engagement and the extent to which these are capable of detecting irregularities, including fraud is detailed below:
∙Enquiry of management, those charged with governance and the entity’s solicitors (or in-house legal team)
Page 7
FACI ECHEM LTD
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF FACI ECHEM LTD
around actual and potential litigation and claims;
∙Enquiry of entity staff in tax and compliance functions to identify any instances of non-compliance with laws and regulations;
∙Performing audit work over the risk of management override of controls, including testing of journal entries and other adjustments for appropriateness, evaluating the business rationale of significant transactions outside the normal course of business and reviewing accounting estimates for bias;
∙Reviewing minutes of meetings of those charged with governance;
∙Performing substantive tests of detail over the completeness/existence of income within the financial system;
∙Performing substantive analytical review procedures reconciling expected income from corroborating evidence to that which had been recorded in the financial statements to ensure that income was complete;
∙Reviewing financial statement disclosures and testing to supporting documentation to assess compliance with applicable laws and regulations.
Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.
A further description of our responsibilities for the audit of the financial statements is located on the FRC’s website at: . This description forms part of our auditor’s report.
Use of our report
This report is made solely to the Company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the Company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company’s members as a body, for our audit work, for this report, or for the opinions we have formed.
for and on behalf of MHA, Statutory Audit
London
United Kingdom
MHA is the trading name of MHA Audit Services LLP, a limited liability partnership in England and Wales (registered number OC455542)
Page 8
FACI ECHEM LTD
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 9
FACI ECHEM LTD
REGISTERED NUMBER: 03847035
BALANCE SHEET
AS AT 31 DECEMBER 2025
The financial statements were approved and authorised for issue by the board and were signed on its behalf on 16 July 2026 .
The notes on pages 12 to 27 form part of these financial statements.
Page 10
FACI ECHEM LTD
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 11
FACI ECHEM LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Faci eChem Ltd is a private limited company, limited by shares, incorporated in England and Wales, registration number 03847035. The registered office is Burley House, 147 Kirkstall Road, Leeds, LS3 1JN.
2.Accounting policies
The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.
The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies (see note 3).
The following principal accounting policies have been applied:
The Company’s parent undertaking, Euchemia Spa, includes the Company in its consolidated financial statements. The consolidated financial statements of Echemia Spa are prepared in accordance with Italian GAAP as adopted by the EU and are available to the public and may be obtained from Camera di Commercia, Genova. In these financial statements, the company is considered to be a qualifying entity (for the purposes of this FRS) and has applied the exemptions available under FRS 102 in respect of the following disclosures;
• Reconciliation of the number of shares outstanding from the beginning to end of the period;
• Cash Flow Statement and related notes; and
• Key Management Personnel compensation.
As the consolidated financial statements of Euchemia Spa include the disclosures equivalent to those required by FRS 102, the Company has also taken the exemptions available in respect of the following disclosures;
Certain disclosures required by FRS 102.11 Basic Financial Instruments and FRS 102.12 Other Financial Instrument Issues in respect of financial instruments not falling within the fair value accounting rules of Paragraph 36(4) of Schedule 1.
• Reconciliation of the number of shares outstanding from the beginning to end of the period;
• Cash Flow Statement and related notes; and
• Key Management Personnel compensation.
As the consolidated financial statements of Euchemia Spa include the disclosures equivalent to those required by FRS 102, the Company has also taken the exemptions available in respect of the following disclosures;
Certain disclosures required by FRS 102.11 Basic Financial Instruments and FRS 102.12 Other Financial Instrument Issues in respect of financial instruments not falling within the fair value accounting rules of Paragraph 36(4) of Schedule 1.
Page 12
FACI ECHEM LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
2.Accounting policies (continued)
The financial statements have been prepared on a going concern basis for a period of at least twelve months from the date of approval of these financial statements.
The Directors have assessed the Company's ability to continue as a going concern taking into consideration its financial performance, forecast cash flows, available financing arrangements and the continued support of the wider FACI Group.
As part of the Group's centralised treasury management arrangements, surplus cash balances are regularly transferred to the parent company, Faci Corporate S.p.A.The Directors are satisfied, by virtue of the involvement of F. Rossi in the board of the ultimate parent company, Euchemia S.p.A., which provides direct knowledge of the Group's financial position and strategic priorities, that the Group has both the intention and the ability to continue making available such funds as are needed by the Company for at least twelve months from the date of approval of these financial statements and for the foreseeable future.
The Directors have reviewed the Company's forecasts and considered the principal risks and uncertainties affecting the business. Based on this assessment, together with the financial resources available within the Group, they have a reasonable expectation that the Company will continue to operate and meet its obligations as they fall due.
Accordingly, the Directors consider it appropriate to prepare the financial statements on the going concern basis.
Functional and presentation currency
Transactions and balances
Page 13
FACI ECHEM LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
2.Accounting policies (continued)
Interest income is recognised in the statement of comprehensive income using the effective interest method. It arises on intercompany balances governed by the Group treasury arrangement, under which amounts are treated as short-term loans for both accounting and tax purposes.
Page 14
FACI ECHEM LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
2.Accounting policies (continued)
The Company is out of scope of the OECD Pillar Two model rules.
Intangible assets are initially recognised at cost and are subsequently carried at cost less accumulated amortisation and any accumulated impairment losses.
All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.
Amortisation is charged on a straight-line basis over the estimated useful life of each asset.
Amortisation is provided on the following bases:
Page 15
FACI ECHEM LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
2.Accounting policies (continued)
Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.
Depreciation is provided on the following basis:
The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.
Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.
Cash and cash equivalents comprise cash balance and call deposits.
Page 16
FACI ECHEM LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
2.Accounting policies (continued)
Provisions are made where an event has taken place that gives the Company a legal or constructive
obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate
can be made of the amount of the obligation.
Provisions are charged as an expense to profit or loss in the year that the Company becomes aware
of the obligation, and are measured at the best estimate at the balance sheet date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties.
When payments are eventually made, they are charged to the provision carried in the Balance Sheet.
Increases in provisions are generally charged as an expense to profit or loss.
obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate
can be made of the amount of the obligation.
Provisions are charged as an expense to profit or loss in the year that the Company becomes aware
of the obligation, and are measured at the best estimate at the balance sheet date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties.
When payments are eventually made, they are charged to the provision carried in the Balance Sheet.
Increases in provisions are generally charged as an expense to profit or loss.
The Company only enters into basic financial instrument transactions. Financial assets and liabilities are recognised when the Company becomes party to the contractual provisions of the instrument.
Short-term financial assets and liabilities, including trade debtors, trade creditors and accruals, are measured at transaction price, being the undiscounted amount expected to be received or paid
.
Intercompany balances arising under the Group treasury arrangement are measured initially at transaction price and subsequently at amortised cost using the effective interest method.
Financial assets are assessed for objective evidence of impairment at each balance sheet date. Where impairment is identified, the carrying amount is reduced accordingly and the loss recognised in profit or loss.
Financial assets and liabilities are offset and the net amount reported in the balance sheet only where there is a legally enforceable right of set-off and an intention to settle on a net basis or simultaneously.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both future and current periods.
There are no accounting estimate or judgements that directors believe require disclosing.
Page 17
FACI ECHEM LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Analysis of turnover by country of destination:
Page 18
FACI ECHEM LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 19
FACI ECHEM LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 20
FACI ECHEM LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
11.Taxation (continued)
Page 21
FACI ECHEM LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
Page 22
FACI ECHEM LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
|
|
||||||
|
|
||||||
|
|
||||||
|
|
||||||
|
|
||||||
|
|
||||||
|
|
||||||
|
|
||||||
|
|
||||||
|
|
||||||
|
|
||||||
|
|
||||||
|
|
||||||
|
|
||||||
|
|
||||||
|
|
||||||
|
|
Page 23
FACI ECHEM LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Page 24
FACI ECHEM LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
Page 25
FACI ECHEM LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
Share premium account
Revaluation reserve
Capital redemption reserve
Profit and loss account
The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.
Charge to the profit and loss during the year was £79,672 (2024 - £75,242) and amount payable at year end was £12,690 (2024 - £10,330 ).
Charge to the profit and loss during the year was £79,672 (2024 - £75,242) and amount payable at year end was £
Page 26
FACI ECHEM LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
The immediate parent company is FACI UK Chemicals Limited , a private company,limited by shares, domiciled in in England and Wales, registered number: 08987602. The company's registered office is Ashcroft Road, Knowsley Industrial Park, Liverpool L33 7TW. The ultimate parent company is Euchemia Spa, a company domiciled in Italy. The company's registered office is Via Privata Devoto 36, Carasco (GE).
Euchemia Spa prepares group financial statements and copies can be obtained from Camera di Commercio, Genova. The company has taken the exemption available in s401 of the Companies Act from the requirement to prepare group financial statements.
Page 27